Latest news
Loading news…
Chondrial Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Bala Cynwyd, Pennsylvania, United States Founded 2013 1-10 employees For Profit
Chondrial Therapeutics is clinical-stage biotechnology that focuses on developing orphan drugs for mitochondrial diseases.
Chondrial Therapeutics was acquired by Larimar Therapeutics in 2019.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
Company Info
- Founded
- 2013
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 2
- HQ
- Bala Cynwyd, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
- Diversity spotlight
- Women Led
- Exit date
- Dec 18, 2019
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.1
- Trend (30d)
- 0.6
- Trend (90d)
- 0
Key People at Chondrial Therapeutics
Vice President of Finance And Operations
Vice President of Regulatory Affairs and Counsel
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Chondrial Therapeutics
Loading news…
FAQs about Chondrial Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.